PharmacogeneticsOxford University Press, 1997 - 344 páginas Genes are important modifiers of human response to drugs, hormones, and toxins. Patients and healthy individuals alike display significant differences in response and suffer adverse effects as a result of exposure to many therapeutic agents as well as occupational chemicals. This introductory text brings together laboratory methods and epidemiological studies for defining the role of heredity in human drug response. The book is divided into two parts. Part I describes the emergence and broad scope of pharmacogenetics from an historical viewpoint, as well as the principles of pharmacology and genetics that are used to evaluate the importance and molecular genetic basis of pharmacologic/toxicologic mechanisms of hypersensitivity in humans and experimental animal models. Part II presents the experimental epidemiologic and clinical evidence for the genetics, molecular basis and clinical significance of thirty-three human traits of pharmacogenetic importance. The author includes an extensive discussion of the role of recombinant DNA technology Thus Part II illustrates the application of the basic principles discussed in Part I to real-life situations. This book will benefit upper-level graduate students in pharmacology, genetics, epidemiology, nursing, and public health, and will serve as a handy reference to pharmacists, epidemiologists, and physicians responsible for the delivery and administration of drugs. |
Índice
Human Drug Response | 21 |
Heredity | 41 |
Drugs and Genes | 71 |
Experimental Models | 93 |
Introduction | 125 |
Human DrugMetabolizing Enzyme Variants | 131 |
Human NonDrugMetabolizing Enzyme Variants | 217 |
Human DrugReceptor Variants | 240 |
Structurally Variant Unidentified Human Proteins | 279 |
Additional Readings | 321 |
Otras ediciones - Ver todo
Términos y frases comunes
a₁-antitrypsin acetylator activity Ah receptor ALAS2 alcohol ALDH2 allele amino acid analysis anticoagulant binding biochemical blood cancer Caucasians cells chemicals cholinesterase chromosome Clin Pharmacol clinical cloning congenic strains cyclophosphamide cystic fibrosis debrisoquine Decreased defect deficiency dehydrogenase diabetes disease disorder distribution dose drug response effects encode enzyme exogenous exons expected number factors frequency fructose G6PD Genetic Aspects genome genotype glutathione Hardy-Weinberg law hepatic hereditary heterozygous homozygous Hum Genet human hypertension identified inbred individuals inheritance insulin receptor investigators isoniazid kinase levels liver loci locus LQTS males malignant hyperthermia markers mechanism mephenytoin metabolism metabolites mice molecular basis mouse mutation NAT2 Nature Genet normal observed oxide paraoxonase patients pedigree pharmacogenetic pharmacological phenotype plasma polymorphism populations protein receptor gene recombinant recombinant congenic strains resistance sensitivity sequence serum slow acetylator steroid studies subunits susceptibility syndrome Table targeting therapeutic agents thiopurine methyltransferase tissues toxicity TPMT twins urinary variability variant vitamin vitamin K warfarin